Regulatory requirements govern the use of raw materials, clinical trials, and non-clinical studies, addressing contamination risks and ethical considerations that may limit raw material utilization. Approval from foreign regulatory authorities is required prior to conducting clinical trials or marketing products, with approval in one jurisdiction not ensuring approval in others. Non-clinical studies must adhere to Good Laboratory Practice (GLP) principles as outlined in EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the European Union must comply with EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCPs), and ethical principles established by the Declaration of Helsinki. Additional European Commission GCP guidelines apply specifically to clinical trials involving Advanced Therapy Medicinal Products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across the EU through the implementation of a centralized Clinical Trials Information System.
Meiragtx Holdings Plc's Comment on Supply Chain
Regulatory requirements govern the use of raw materials, clinical trials, and non-clinical studies, addressing contamination risks and ethical considerations that may limit raw material utilization. Approval from foreign regulatory authorities is required prior to conducting clinical trials or marketing products, with approval in one jurisdiction not ensuring approval in others. Non-clinical studies must adhere to Good Laboratory Practice (GLP) principles as outlined in EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the European Union must comply with EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCPs), and ethical principles established by the Declaration of Helsinki. Additional European Commission GCP guidelines apply specifically to clinical trials involving Advanced Therapy Medicinal Products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across the EU through the implementation of a centralized Clinical Trials Information System.
Sources:
Meiragtx Holdings Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Meiragtx Holdings Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
